Published On : May 2022 Pages : 97 Category: Medical Devices Report Code : HC058
Industry Trends Analysis
Deep brain stimulation market is expected to be around $3.2 billion by 2027. Rising number of people suffering from Parkinson’s disease and increased awareness about neurological disorders is driving the market globally. DBS can be used to treat various neurological disorders such as dystonia, Parkinson’s disease, epilepsy, Tourette syndrome, obsessive compulsive disorders, and chronic pain. According to WHO, neurological disorders category contributes to % of global burden of diseases. DBS also has major applications in controlling movement disorders. After Alzheimer’s disease, Parkinson’s disease is the most common neurological disorder. However, the high cost of the devices and risk of infection at the stimulator site are some of the factors restraining the market growth.
Application Outlook and Trend Analysis
The Parkinson’s disease segment is expected to register steady growth over the forecast period. Deep brain stimulation is most commonly used to treat Parkinson’s disease which is one of the most common neurological disorders. Due to its benefits in tracking short term symptom fluctuations, DBS offers great value in treating Parkinson’s disease. Obsessive compulsive disorder and dystonia segments are the next largest segments after Parkinson’s disease. DBS aids in enhancing the quality of life by improving motor symptoms in patients. Deep brain stimulation has wide applications in pain management.
Regional Outlook and Trend Analysis
North America dominated the global deep brain stimulation market in 2017, due to the presence of advanced healthcare infrastructure along with favorable reimbursement policies. On the other hand, Asia-Pacific market is expected to exhibit significant growth over the forecast period. Increased disposable income and improved healthcare expenditure in emerging economies such as India and China will drive the growth of this market.
Competitive Analysis
Medtronic Plc, St. Jude Medical, Boston Scientific Corporation, EnteroMedics, Cyberonics, Zynex and Aleva Neurotherapeutics SA are the major companies operating in the global deep brain stimulation market.
Acquisition is one of the key strategies adopted by the major players in DBS market. For instance, Medtronic acquired Sapiens Steering Brain Stimulation to extend its product portfolio in the deep brain stimulation market.
Market Opportunities
Increasing cases of different neurological disorders, rise in age related neurological disorders, rapidly growing elderly population, and increased awareness about the availability of different treatments for neurological disorders propose significant opportunities for the growth of DBS market globally. Further, technological advancements to improve the functionality of these devices will boost the acceptance of these devices rapidly on a global level. The rising acceptance of these devices over drugs that may lead to side effects is another indicator of rising opportunities for market growth.
Deep Brain Stimulation Market Segmentation:
By Application:
By Region:
Some of the key questions answered by the report are:
Market Classification
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Cases of Parkinson’s Disease Globally
3.3.1.2. Increased Awareness about Neurological Movement Disorders
3.3.2. Restraints
3.3.2.1. High Cost of the Devices
3.3.2.2. Risk of Infection at the Stimulator Site
3.3.3. Opportunities
3.3.3.1. Technological Advancements to Improve Functionality of these Devices
3.4. Industry Trends
4. Deep Brain Stimulation Market, By Application
4.1. Introduction
4.2. Deep Brain Stimulation Market Assessment and Forecast, By Application, 2017-2027
4.2.1. Parkinson’s Disease
4.2.1.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.2.2. Epilepsy
4.2.2.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.2.3. Obsessive-Compulsive Disorder (OCD)
4.2.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.2.4. Dystonia
4.2.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.2.5. Pain Management
4.2.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.2.6. Depression
4.2.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.2.7. Other Applications
4.2.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Deep Brain stimulation Market, By Region
5.1. Introduction
5.2. Deep Brain stimulation Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.3. North America
5.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.3.2.1. U.S.
5.3.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.3.2.2. Canada
5.3.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.3.2.3. Mexico
5.3.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4. Europe
5.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4.2.1. Germany
5.4.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4.2.2. France
5.4.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4.2.3. UK
5.4.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4.2.4. Italy
5.4.2.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4.2.5. Spain
5.4.2.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4.2.6. Russia
5.4.2.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.4.2.7. Rest of Europe
5.4.2.7.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5. Asia-Pacific
5.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.5.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5.2.1. Japan
5.5.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5.2.2. China
5.5.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5.2.3. Australia
5.5.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5.2.4. India
5.5.2.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5.2.5. South Korea
5.5.2.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5.2.6. Taiwan
5.5.2.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.5.2.7. Rest of Asia-Pacific
5.5.2.7.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.6. Rest of the World
5.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.6.2.1. Brazil
5.6.2.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.6.2.2. Turkey
5.6.2.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.6.2.3. Saudi Arabia
5.6.2.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.6.2.4. South Africa
5.6.2.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.6.2.5. United Arab Emirates
5.6.2.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
5.6.2.6. Others
5.6.2.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6. Company Profiles
6.1. Medtronic Plc
6.1.1. Business Overview
6.1.2. Product Portfolio
6.1.3. Key Financials
6.1.4. Strategic Developments
6.2. Boston Scientific Corporation
6.2.1. Business Overview
6.2.2. Product Portfolio
6.2.3. Key Financials
6.2.4. Strategic Developments
6.3. St. Jude Medical
6.3.1. Business Overview
6.3.2. Product Portfolio
6.3.3. Key Financials
6.3.4. Strategic Developments
6.4. Aleva Neurotherapeutics SA.
6.4.1. Business Overview
6.4.2. Product Portfolio
6.4.3. Key Financials
6.4.4. Strategic Developments
6.5. Enteromedics
6.5.1. Business Overview
6.5.2. Product Portfolio
6.5.3. Key Financials
6.5.4. Strategic Developments
6.6. Cyberonics, Inc.
6.6.1. Business Overview
6.6.2. Product Portfolio
6.6.3. Key Financials
6.6.4. Strategic Developments
6.7. Zynex
6.7.1. Business Overview
6.7.2. Product Portfolio
6.7.3. Key Financials
6.7.4. Strategic Developments
List of Tables
Table 1.Global Deep Brain Stimulation Market, By Application, 2017-2025($Million)
Table 2.Parkinson s Disease Market, By Region, 2017-2025($Million)
Table 3.Epilepsy Market, By Region, 2017-2025($Million)
Table 4.Obsessive-Compulsive Disorder Market, By Region, 2017-2025($Million)
Table 5.Dystonia Market, By Region, 2017-2025($Million)
Table 6.Pain Management Market, By Region, 2017-2025($Million)
Table 7.Depression Market, By Region, 2017-2025($Million)
Table 8.Other Applications Market, By Region, 2017-2025($Million)
Table 9.Deep Brain Stimulation Market, By Region, 2017-2025($Million)
Table 10.North America Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 11.North America Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 12.U.S. Deep Brain Stimulation Market, by Application, 2017-2025 ($Million)
Table 13.Canada Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 14.Mexico Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 15.Europe Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 16.Europe Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 17.Germany Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 18.France Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 19.UK Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 20.Italy Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 21.Spain Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 22.Russia Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 23.Rest of Europe Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 24.Asia-Pacific Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 25.Asia-Pacific Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 26.Japan Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 27.China Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 28.Australia Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 29.India Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 30.South Korea Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 31.Taiwan Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 32.Rest of Asia-Pacific Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 33.Rest of the World Deep Brain Stimulation Market, By Country, 2017-2025 ($Million)
Table 34.Rest of the World Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 35.Brazil Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 36.Turkey Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 37.Saudi Arabia Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 38.South Africa Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 39.United Arab Emirates Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 40.Others Deep Brain Stimulation Market, By Application, 2017-2025 ($Million)
Table 41.Medtronic Plc: Key Strategic Developments, 2017-2017
Table 42.Boston Scientific Corporation: Key Strategic Developments, 2017-2017
Table 43.St. Jude Medical: Key Strategic Developments, 2017-2017
Table 44.Aleva Neurotherapeutics SA: Key Strategic Developments, 2017-2017
Table 45.Enteromedics: Key Strategic Developments, 2017-2017
Table 46.Cyberonics, Inc.: Key Strategic Developments, 2017-2017
Table 47.Zynex: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Deep Brain Stimulation Market Share, By Application, 2017 & 2025
Figure 2 Deep Brain Stimulation Market, By Region, 2017 ($Million)
Figure 3.Medtronic Plc: Net Revenues, 2017-2017 ($Million)
Figure 4.Medtronic Plc: Net Revenue Share, By Segment, 2017
Figure 5.Medtronic Plc: Net Revenue Share, By Geography, 2017
Figure 6.Boston Scientific Corporation: Net Revenues, 2017-2017 ($Million)
Figure 7.Boston Scientific Corporation: Net Revenue Share, By Segment, 2017
Figure 8.Boston Scientific Corporation: Net Revenue Share, By Geography, 2017
Figure 9.St. Jude Medical: Net Revenues, 2017-2017 ($Million)
Figure 10.St. Jude Medical: Net Revenue Share, By Segment, 2017
Figure 11.St. Jude Medical: Net Revenue Share, By Geography, 2017
Figure 12.Aleva Neurotherapeutics SA.: Net Revenues, 2017-2017 ($Million)
Figure 13.Aleva Neurotherapeutics SA.: Net Revenue Share, By Segment, 2017
Figure 14.Aleva Neurotherapeutics SA.: Net Revenue Share, By Geography, 2017
Figure 15.Enteromedics: Net Revenues, 2017-2017 ($Million)
Figure 16.Enteromedics: Net Revenue Share, By Segment, 2017
Figure 17.Enteromedics: Net Revenue Share, By Geography, 2017
Figure 18.Cyberonics, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 19.Cyberonics, Inc.: Net Revenue Share, By Segment, 2017
Figure 20.Cyberonics, Inc.: Net Revenue Share, By Geography, 2017
Figure 21.Zynex: Net Revenues, 2017-2017 ($Million)
Figure 22.Zynex: Net Revenue Share, By Segment, 2017
Figure 23.Zynex: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix |
Supply Side |
Demand Side |
Primary Data Sources |
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
Qualitative Data |
Quantitative Data (2017-2025) |
|
|